Join the Leqembi group to help and get support from people like you.
Leqembi News
Could a 'Brain Coach' Help Folks at Higher Risk for Alzheimer's?
TUESDAY, Nov. 28, 2023 – Personal trainers can help people increase their strength and their fitness. Could a “brain coach” be just as useful in preventing Alzheimer’s’ disease? A new study suggests ...
Eligibility Limited for Anti-β Amyloid mAbs in Seniors With MCI
FRIDAY, Aug. 18, 2023 – Older adults with cognitive impairment have limited eligibility for anti-β amyloid monoclonal antibodies when applying clinical trial criteria, according to a study published ...
Most Alzheimer's Patients May Be Ineligible for Newly Approved Drugs
THURSDAY, Aug. 17, 2023 – Two recently approved treatments offer newfound hope for patients in the early stages of Alzheimer’s disease, but most people who could benefit will likely be deemed i...
Are These Pricey New Alzheimer's Drugs Worth It?
MONDAY, July 24, 2023 – Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research. The fact that patients’ mental deterioration sl...
FDA Grants Traditional Approval for Leqembi (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., July 06, 2023 (GLOBE NEWSWIRE) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Mas...
FDA Gives Full Approval to Alzheimer’s Drug Leqembi
THURSDAY, July 6, 2023 – The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer's drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full F...
FDA Approves Leqembi (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease
Accelerated Approval is based on Phase 2 data showing a reduction in amyloid-beta plaques in early AD patients treated with Leqembi™ Treatment with Leqembi should be initiated in patients with mild c...
Ask a question
To post your own question to this support group, sign in or create an account.